The 4th Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2024 is hosting an online meeting with subject matter experts to address challenges related to mutagenic impurities. Impurities can impact pharmaceutical efficacy, safety, and quality, necessitating thorough assessment and management. In collaboration with industry professionals, the summit aims to discuss strategies for identifying and managing genotoxic contaminants, including nitrosamines. Topics include adherence to regulatory guidelines, updates to ICH M7 and Q3D, nitrosamine impurity determination, risk assessment, analytical challenges, and elemental impurity assessment. Participants will gain insights into nitrosamine risk assessment, contamination minimization, appropriate analytical tools, and practical application of regulatory guidance. Reserve a spot for this webinar to glean new ideas and best practices for impurity management.

 [Read on uventia.com](https://www.uventia.com/event/4th-annual-genotoxic-impurities-summit-nitrosamines-beyond-2024/)

Continue reading at uventia.com

Genomics

Facebook Share

Twitter Share

Linkedin Share

Email Share